clavulanic acid has been researched along with rifampin in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Aubé, J; Ballinger, E; Dartois, V; Gold, B; Hanson, P; Ling, Y; Little, D; Lopez Quezada, L; Mitscher, LA; Nathan, C; Nguyen, Q; Pingle, M; Porubsky, P; Roberts, J; Rogers, S; Schoenen, FJ; Smith, R; Somersan, S; Warrier, T; Zhang, D; Zimmerman, M | 1 |
Bergeron, MG; L'Ecuyer, J; Provencher, P; Tremblay, LD | 1 |
Schmid, GP | 1 |
Bernard, P; Conscience, I; Le Berruyer, PY; Perceau, G | 1 |
Baldin, VP; Caleffi-Ferracioli, KR; Cardoso, RF; Leite, CQ; Lopes, MA; Pagliotto, AD; Pavan, FR; Scodro, RB; Siqueira, VL | 1 |
Arenaz-Callao, MP; González Del Río, R; Lucía Quintana, A; Mendoza-Losana, A; Ramón-García, S; Thompson, CJ | 1 |
Barth, SA; Häußler, TC; Köhler, K; Prenger-Berninghoff, E; Thom, N | 1 |
1 review(s) available for clavulanic acid and rifampin
Article | Year |
---|---|
The treatment of chancroid.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Chancroid; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Erythromycin; Haemophilus ducreyi; Humans; Penicillin Resistance; Rifampin; Sulfonamides; Trimethoprim | 1986 |
1 trial(s) available for clavulanic acid and rifampin
Article | Year |
---|---|
The treatment of chancroid.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Chancroid; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Erythromycin; Haemophilus ducreyi; Humans; Penicillin Resistance; Rifampin; Sulfonamides; Trimethoprim | 1986 |
13 other study(ies) available for clavulanic acid and rifampin
Article | Year |
---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cells, Cultured; Cephalosporins; Female; Hep G2 Cells; Humans; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2016 |
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Canada; Cefaclor; Cefamandole; Cefazolin; Cefotaxime; Cefuroxime; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Haemophilus influenzae; Rifampin; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
[Bilateral breast bacterial cellulite secondary to Streptococcus agalactiae septicemia].
Topics: Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breast Diseases; Cellulitis; Clavulanic Acid; Colonic Polyps; Colonoscopy; Drug Therapy, Combination; Female; Humans; Metronidazole; Rifampin; Sepsis; Sigmoid Neoplasms; Streptococcal Infections; Streptococcus agalactiae; Time Factors; Treatment Outcome | 2006 |
Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
Topics: Amoxicillin; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Rifampin; Xanthenes | 2016 |
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening.
Topics: Administration, Oral; Amoxicillin; beta-Lactamase Inhibitors; beta-Lactamases; Buruli Ulcer; Clarithromycin; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium ulcerans; Rifampin | 2019 |
Challenging diagnosis and successful treatment of localised
Topics: Alkaline Phosphatase; Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Clavulanic Acid; Dog Diseases; Dogs; Doxycycline; Female; Glossitis; Immunomodulation; Mycobacterium; Mycobacterium avium; Rifampin | 2022 |